Key Takeaways RVMD stock surged nearly 29% after a WSJ report cited possible AbbVie acquisition interest.ABBV later denied takeover talks, though the report said a deal could value RVMD at $20B or more.Revolution Medicines develops RAS(ON) cancer drugs, with lead candidate daraxonrasib in late-stage studies.Shares of Revolution Medicines (RVMD) rose nearly 29% on Wednesday following a report issued by the Wall Street Journal (WSJ), as cited in a Yahoo Finance article, which stated that pharma giant AbbVie ( ...